Cite
A randomized, double-blind, placebo-controlled trial of Ad5FGF-4 gene therapy and its effect on myocardial perfusion in patients with stable angina.
MLA
Grines CL, et al. “A Randomized, Double-Blind, Placebo-Controlled Trial of Ad5FGF-4 Gene Therapy and Its Effect on Myocardial Perfusion in Patients with Stable Angina.” Journal of the American College of Cardiology (JACC), vol. 42, no. 8, Oct. 2003, pp. 1339–47. EBSCOhost, https://doi.org/10.1016/s0735-1097(03)00988-4.
APA
Grines CL, Watkins MW, Mahmarian JJ, Iskandrian AE, Rade JJ, Marrott P, Pratt C, Kleiman N, Angiogenic GENe Therapy (AGENT-2) Study Group, Grines, C. L., Watkins, M. W., Mahmarian, J. J., Iskandrian, A. E., Rade, J. J., Marrott, P., Pratt, C., Kleiman, N., & Angiogene GENe Therapy (AGENT-2) Study Group. (2003). A randomized, double-blind, placebo-controlled trial of Ad5FGF-4 gene therapy and its effect on myocardial perfusion in patients with stable angina. Journal of the American College of Cardiology (JACC), 42(8), 1339–1347. https://doi.org/10.1016/s0735-1097(03)00988-4
Chicago
Grines CL, Watkins MW, Mahmarian JJ, Iskandrian AE, Rade JJ, Marrott P, Pratt C, et al. 2003. “A Randomized, Double-Blind, Placebo-Controlled Trial of Ad5FGF-4 Gene Therapy and Its Effect on Myocardial Perfusion in Patients with Stable Angina.” Journal of the American College of Cardiology (JACC) 42 (8): 1339–47. doi:10.1016/s0735-1097(03)00988-4.